Clinical Trial Update: Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing the safety and tolerability of MEDI-545 in patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MEDI-545

Snippet

Sponsor: MedImmune LLC | Conditions: Lupus | Phase 1 | Status: COMPLETED